Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...
The Under-oil Open Microfluidic System enhances tumor cell-ECM interaction studies, improving anti-metastatic drug testing ...
Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...
Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.
A new way to grow T cells in the lab enables them to live longer and better destroy cancer cells in a mouse model of melanoma ...
Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...
A new deep learning model shows promise in detecting and segmenting lung tumors. The findings of the study could have ...
The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.